His research on Pathology frequently connects to adjacent areas such as Kupffer cell. His study brings together the fields of Pathology and Kupffer cell. His research is interdisciplinary, bridging the disciplines of Focal nodular hyperplasia and Internal medicine. His Focal nodular hyperplasia study frequently draws connections between adjacent fields such as Internal medicine. Many of his studies on Hepatocellular carcinoma involve topics that are commonly interrelated, such as HCCS. HCCS and Hepatocellular carcinoma are commonly linked in his work. His Cell growth study frequently draws connections between related disciplines such as Genetics. His study ties his expertise on Carcinogenesis together with the subject of Genetics. Masamichi Kojiro conducts interdisciplinary study in the fields of Carcinogenesis and Tumor progression through his works.
In his research, Masamichi Kojiro performs multidisciplinary study on Internal medicine and Endocrinology. His work blends Endocrinology and Internal medicine studies together. He undertakes interdisciplinary study in the fields of Hepatocellular carcinoma and Focal nodular hyperplasia through his research. In his articles, Masamichi Kojiro combines various disciplines, including Focal nodular hyperplasia and Hepatocellular carcinoma. His Cancer research study frequently intersects with other fields, such as HCCS. His work on HCCS is being expanded to include thematically relevant topics such as Cancer research. He connects Pathology with Immunohistochemistry in his study. He conducted interdisciplinary study in his works that combined Immunohistochemistry and Pathology. His work in Immunology is not limited to one particular discipline; it also encompasses Interferon.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Angiogenesis in cancer.
Naoyo Nishida;Hirohisa Yano;Takashi Nishida;Toshiharu Kamura.
Vascular Health and Risk Management (2006)
Prospective Cohort Study of Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma in 8510 Patients
Kenichi Takayasu;Shigeki Arii;Iwao Ikai;Masao Omata.
Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version
Masatoshi Kudo;Namiki Izumi;Norihiro Kokudo;Osamu Matsui.
Digestive Diseases (2011)
Pathologic Diagnosis of Early Hepatocellular Carcinoma: A Report of the International Consensus Group for Hepatocellular Neoplasia
Masamichi Kojiro;Ian R. Wanless;Venancio Alves;Sunil Badve.
Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan
Shigeki Arii;Yoshio Yamaoka;Syunji Futagawa;Kyoichi Inoue.
Pathology of hepatocellular carcinoma in Japan. 232 Consecutive cases autopsied in ten years.
Toshiro Nakashima;Kunio Okuda;Masamichi Kojiro;Atsuro Jimi.
Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers.
Tania A. Roskams;Neil D. Theise;Charles Balabaud;Govind Bhagat.
Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey.
Iwao Ikai;Shigeki Arii;Masamichi Kojiro;Takafumi Ichida.
Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation.
Hironori Koga;Shotaro Sakisaka;Masahito Ohishi;Takumi Kawaguchi.
Expression of vascular endothelial growth factor in human hepatocellular carcinoma
Rin Yamaguchi;Hirohisa Yano;Akihiro Iemura;Sachiko Ogasawara.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: